Impaired glucose metabolism in irritable bowel syndrome: personalised low-glycaemic diet as potential therapeutic target. Schmelter F, Schroder T, Laumonnier Y, Bischoff SC, et al. Gut 2025 Oct 5:gutjnl-2025-336797. doi: 10.1136/gutjnl-2025-336797.

Read + Share

Amedeo Smart

Independent Medical Education

Schmelter F, Schroder T, Laumonnier Y, Bischoff SC, et al. Impaired glucose metabolism in irritable bowel syndrome: personalised low-glycaemic diet as potential therapeutic target. Gut 2025 Oct 5:gutjnl-2025-336797. doi: 10.1136/gutjnl-2025-336797.
PMID: 41047175